GLP-1 Advice on Social Media: Red Flags in Viral Tips

Social media can help people find community around GLP-1 treatment, but it can also spread unsafe instructions with enormous confidence. A post can be completely sincere and still be wrong. The most useful skill isn't memorizing every drug name—it's spotting the claims that deserve a closer look.

Eight red flags worth noticing

Be cautious when a post:

1. Promises a guaranteed amount of weight loss. Trial results are averages, and individual responses vary widely.
2. Tells everyone to increase a dose on a particular week. Dose schedules come from your prescriber and your product's label, not a one-size-fits-all timeline.
3. Recommends combining medicines or "stacking" products without a prescriber involved.
4. Sells "research peptides" or products labeled "not for human consumption." The FDA has warned companies selling semaglutide, tirzepatide and even investigational drugs such as retatrutide this way, and urges consumers not to buy them.
5. Claims a compounded product is FDA-approved. Compounded drugs are not FDA-approved, and the agency does not review them for safety, effectiveness or quality before they're sold.
6. Says serious symptoms prove the drug is working. Severe or persistent symptoms deserve medical attention, not encouragement to push through.
7. Shares dose "conversions" in units or clicks. The FDA has received reports of people hospitalized after dosing errors with compounded semaglutide, often from confusion between units, milliliters and milligrams.
8. Shows a dramatic before-and-after photo with no timeframe, no context and a product link. (We dig into this in why before-and-after stories don't tell the whole story.)

Check who is making the claim

Is the source a regulator, a peer-reviewed study, a clinician explaining evidence, a person sharing their own experience, or someone selling something? All of these can offer different kinds of information, but they aren't interchangeable. A personal story can tell you how something felt; it can't tell you how common an experience is or prove a medicine caused it.

Look for the study details

When a post cites research, check which medicine, dose and population were studied, how long people were followed, what outcome was measured, and whether the study was randomized or observational. Company press releases should be read as sponsor-reported results until the full data are published and assessed. An abstract, a small pilot or an animal study doesn't answer every question about real-world safety—and a drug still in trials isn't the same as an approved medicine (see investigational vs approved drugs).

Use official information for action

For anything you'd actually act on—how to take a medicine, missed doses, interactions, who shouldn't use it—the right sources are your product's current leaflet and a qualified prescriber or pharmacist. Approval status also differs by country and product, so a post from one country may not apply where you live. As of October 2026, the FDA also reports finding counterfeit Ozempic in the US supply chain, which is another reason to fill prescriptions through licensed pharmacies.

Keep the helpful part of online community

Peer support can ease loneliness and help you put your questions into words. Use it to collect topics for your next clinician conversation, not as a substitute for individualized care. If a post leaves you feeling pressured to take more, eat less, buy something or hide symptoms, it's a good moment to step back.

A useful rule of thumb: stay curious, but verify before changing anything about your treatment.